Literature DB >> 24257743

Pharmacists' role in addressing opioid abuse, addiction, and diversion.

.   

Abstract

OBJECTIVE To review the scope of the problem of opioid misuse; explore pharmacists' roles and responsibilities regarding opioid use; discuss existing laws, guidelines, and regulations governing opioid management; identify potential patient and practice management strategies to address opioid abuse; and disseminate leader insights on these issues. DATA SOURCES Information presented at a conference convened by the American Pharmacists Association (Pharmacists' Role in Addressing Opioid Abuse, Addiction, and Diversion; held November 15, 2012) and discussed in conference workgroups, as well as related information from the literature. SUMMARY Opioid misuse, abuse, and diversion has grown dramatically since the early 1990s and affects public health considerably. In 2011, more individuals died from drug overdoses than from motor vehicle accidents. Strategies are available that pharmacists can use to reduce the likelihood of opioid misuse, abuse, and diversion while minimizing the impact on legitimate pain management efforts. These strategies and tools can be used to support (1) the assessment of prescriptions that are presented for opioid medications, (2) the management of patients receiving opioids, and (3) follow-up options when misuse, abuse, or diversion has been identified. CONCLUSION Implementation of systems and processes that support pharmacist management of opioid-related issues under financially viable business models would create a number of opportunities to improve patient care.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24257743     DOI: 10.1331/JAPhA.2014.13101

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  10 in total

1.  A Laboratory Session to Prepare Pharmacy Students to Manage the Opioid Crisis Situation.

Authors:  Krista L Donohoe; Archana Raghavan; Thuy T Tran; Fawaz M Alotaibi; Kacie E Powers; Laura M Frankart
Journal:  Am J Pharm Educ       Date:  2019-09       Impact factor: 2.047

2.  Behavioral, mental, and physical health characteristics and opioid medication misuse among community pharmacy patients: A latent class analysis.

Authors:  Gerald Cochran; Valerie Hruschak; Jennifer L Bacci; Kenneth C Hohmeier; Ralph Tarter
Journal:  Res Social Adm Pharm       Date:  2016-11-15

3.  Pharmacists' Role in Opioid Safety: A Focus Group Investigation.

Authors:  Daniel M Hartung; Jennifer Hall; Sarah N Haverly; David Cameron; Lindsey Alley; Christi Hildebran; Nicole O'Kane; Deborah Cohen
Journal:  Pain Med       Date:  2018-09-01       Impact factor: 3.750

4.  An evaluation of Alberta pharmacists' practices, views and confidence regarding prescription drug abuse and addiction within their practice setting.

Authors:  Candace Necyk; Ken Cor; Arianna Mazzuca; Lauren Meleshko
Journal:  Can Pharm J (Ott)       Date:  2019-08-13

5.  "People need them or else they're going to take fentanyl and die": A qualitative study examining the 'problem' of prescription opioid diversion during an overdose epidemic.

Authors:  Geoff Bardwell; Will Small; Jennifer Lavalley; Ryan McNeil; Thomas Kerr
Journal:  Soc Sci Med       Date:  2021-05-03       Impact factor: 5.379

6.  Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.

Authors:  Li-Tzy Wu; William S John; Udi E Ghitza; Aimee Wahle; Abigail G Matthews; Mitra Lewis; Brett Hart; Zach Hubbard; Lynn A Bowlby; Lawrence H Greenblatt; Paolo Mannelli
Journal:  Addiction       Date:  2021-01-11       Impact factor: 7.256

7.  Strategies and policies to address the opioid epidemic: A case study of Ohio.

Authors:  Jonathan Penm; Neil J MacKinnon; Jill M Boone; Antonio Ciaccia; Cameron McNamee; Erin L Winstanley
Journal:  J Am Pharm Assoc (2003)       Date:  2017-02-08

8.  Evaluation and optimization of take-home naloxone in an academic medical center.

Authors:  Jordan Cooler; Clint A Ross; Sophie Robert; Lauren Linder; Ann Marie Ruhe; Achsah Philip
Journal:  Ment Health Clin       Date:  2019-03-01

9.  Assessing pharmacy student experience with, knowledge of and attitudes towards harm reduction: illuminating barriers to pharmacist-led harm reduction.

Authors:  Lily Rowan Mahon; Amanda N Hawthorne; Julie Lee; Heather Blue; Laura Palombi
Journal:  Harm Reduct J       Date:  2018-11-16

10.  Differences between pharmacists' perception of counseling and practice in the era of prescription drug misuse.

Authors:  J Douglas Thornton; Precious Anyanwu; Vaishnavi Tata; Tamara Al Rawwad; Marc L Fleming
Journal:  Pharm Pract (Granada)       Date:  2020-02-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.